Multivariate analysis of the relation between immune dysfunction and treatment intensity in children with acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 56, Issue 7, 2011, Pages 1078-1087

  Ek, Torben ^a   Josefson, Mats ^b   Abrahamsson, Jonas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

ALL; Immunology; Leukemia

Indexed keywords

ASPARAGINASE; CD45RA ANTIGEN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNOCOMPETENCE; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; DIPHTHERIA TOXOID; FEMALE; FLOW CYTOMETRY; HAEMOPHILUS VACCINES; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULINS; LYMPHOCYTE SUBSETS; MALE; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; TETANUS TOXOID; TREATMENT OUTCOME;

EID: 79954482095     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23043     Document Type: Article

References (27)

1. Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: The St. Jude experience. Cancer. 2004; 101: 1677-1684.
2. Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up. Acta Paediatr 1995; 84: 177-182.
3. Nilsson A, De Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002; 109: e91.
4. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84: 2221-2228.
5. Haining WN, Neuberg DS, Keczkemethy HL, et al. Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood 2005; 106: 1749-1754.
6. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
7. Lehrnbecher T, Foster C, Vazquez N, et al. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 1997; 19: 399-417.
8. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Pediatr Oncol 1995; 24: 373-378.
9. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992; 69: 1481-1486.
10. McCusker C, Somerville W, Grey V, et al. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. Ann Allergy Asthma Immunol 1997; 79: 145-150.
11. Ek T, Mellander L, Hahn-Zoric M, et al. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol 2004; 26: 727-734.
12. Ek T, Mellander L, Andersson B, et al. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005; 44: 461-468.
13. Jackson J. A users guide to principal components. New York: Wiley; 1991.
14. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemometrics Intell Lab Syst 1987; 2: 37-52.
15. Wold S, Albano C, Dunn W, et al. Multivariate data analysis in chemistry. In: Kowalski BR, editor. Chemometrics: Mathematics and statistics in chemistry. Dordrecht, Holland: D. Reidel Publishing Company; 1984.
16. Wold S, Sjöström M, Eriksson L. PLS-regression:a basic tool of chemometrics. Chemometrics Intell Lab Syst 2001; 58: 109-130.
17. Gustafsson G, Kreuger A, Clausen N, et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996.Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatr 1998; 87: 1151-1161.
18. Saarinen-Pihkala UM, Gustafsson G, Carlsen N, et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer 2004; 42: 8-23.
19. Qvarfordt I, Riise GC, Larsson S, et al. Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations. Eur Respir J 1998; 11: 46-54.
20. Ek T, Mellander L, Hahn-Zoric M, et al. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia-Implications for vaccination strategies. Acta Paediatr 2006; 95: 701-706.
21. Eastment HTKW. Cross-validatory choice of the number of components from a principal component analysis. Technometrics 1982; 24: 5.
22. Wold S, Johansson E, Cocchi M. PLS-Partial least squares projections to latent structures. In: Kubinyi H, editor. 3D QSAR in drug design: Theory, methods, and applications. Dordrecht: Kluwer Academic Publishers; 1993. pp. 523-550.
23. Eriksson LJE, Kettaneh-Wold N, Trygg J, et al. Multi- and megavariate data analysis. Part I. Basic principles and applications, 2nd edition. Umeå: Umetrics Academy; 2006.
24. van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: A systematic review. Leukemia 2006; 20: 1717-1722.
25. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997; 160: 91-102.
26. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253-300.
27. Blanca IR, Bere EW, Young HA, et al. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: Role of memory B cells and CD5+ B cells. J Immunol 2001; 167: 6132-6139.